SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000878088-12-000055
Filing Date
2012-10-02
Accepted
2012-10-02 14:44:55
Documents
5
Period of Report
2012-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8ktpgclosing92812.htm 8-K 26364
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION echibit3_1charterpostclosing.htm EX-3.1 18748
3 AMENDED AND RESTATED BY-LAWS amendedandrestatedbylaws.htm EX-3.2 51654
4 JOINT PRESS RELEASE f92812tpgcompletesacquisitio.htm EX-99.1 7186
5 f92812tpgcompletesacquisi001.gif GRAPHIC 5195
  Complete submission text file 0000878088-12-000055.txt   112707
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10827 | Film No.: 121122929
SIC: 2834 Pharmaceutical Preparations